, 16:405
Date: 22 Jan 2014

Management of Recurrent Thrombosis in Antiphospholipid Syndrome

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


One of the challenges of managing patients with antiphospholipid syndrome is the prevention of rethrombosis (secondary prophylaxis). Risk stratification, i.e. traditional cardiovascular and thrombosis risk factors, systemic autoimmune diseases, antiphospholipid antibody profile, and the intensity of anticoagulation are all relevant to the management of APS patients with recurrent thrombosis. The paper will review “state of the art” strategies for optimizing therapy for APS patients with recurrent thrombosis.